Orphan Drug Act deals with (2) Ex?,”Offers financial incentives to organizations that develop and market orphan drugs. These are medications that are used for the treatment of a disease or condition that affects fewer than 200,000 patients This act offers tax breaks and a seven-year monopoly on the drug’s patentMedications like Syprine, a chelating agent, was developed to treat the rare Wilson’s Disease—which involves the body’s inability to remove copper. Another example is Pamisyl

Average Rating
0 out of 5 stars. 0 votes.

Orphan Drug Act deals with (2) Ex?,”Offers financial incentives to organizations that develop and market orphan drugs. These are medications that are used for the treatment of a disease or condition that affects fewer than 200,000 patients This act offers tax breaks and a seven-year monopoly on the drug’s patentMedications like Syprine, a chelating agent, was developed to treat the rare Wilson’s Disease—which involves the body’s inability to remove copper. Another example is Pamisyl

which is used to treat ulcerative colitis.”